Weight loss injections like semaglutide (Ozempic and Wegovy) have been associated with potential psychological side effects, including depression, anxiety, and suicidal thoughts or ideation, with the FDAs adverse event reporting system has received 489 reports of patients experiencing anxiety, depression, or suicidal thoughts
GLP-1s suppress appetite through hypothalamic receptor activation
The safety profile was favorable, with no serious drug-related adverse events reported in the trial
Within three weeks of their launch in the United States on Jan
Specifically, after a challenge dose of alcohol, participants in the GLP-1RA group have a delayed rise in BrAC and a similar delayed rise in the subjective effects of alcohol
[online] Wellnessresources.com